AstraZeneca
AZN
#64
Rank
NZ$441.13 B
Marketcap
NZ$284.44
Share price
1.20%
Change (1 day)
10.21%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2026 (TTM): NZ$11.96

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is NZ$12.07. In 2024 the company made an earnings per share (EPS) of NZ$7.88 an increase over its 2023 EPS that were of NZ$6.67.

EPS history for AstraZeneca from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$11.96
2024NZ$7.8818.23%
2023NZ$6.6781.13%
2022NZ$3.68631.03%
2021NZ$0.50-88.11%
2020NZ$4.24136.89%
2019NZ$1.79-39.41%
2018NZ$2.95-28.27%
2017NZ$4.12-14.37%
2016NZ$4.8124.11%
2015NZ$3.87127.55%
2014NZ$1.70-51.96%
2013NZ$3.54-58.95%
2012NZ$8.63-32.2%
2011NZ$12.73

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.17 25.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.19 1.01%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.27-81.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.27-48.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$49.02 306.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$4.45-63.17%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$16.24 34.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.21-48.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$6.18-48.78%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.75-44.08%๐Ÿ‡ฌ๐Ÿ‡ง UK